-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, W0XWfNEpsf1+ygJ3Wag40tLWnwoZfFnBEDMfMK8IydSOfvJ16Lgx9HV+Y7ykaYdP 8p2nxs9LfnJeC0+v1wuFTQ== 0000912057-01-004174.txt : 20010208 0000912057-01-004174.hdr.sgml : 20010208 ACCESSION NUMBER: 0000912057-01-004174 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010207 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ARGOSY EDUCATION GROUP INC CENTRAL INDEX KEY: 0001070042 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-EDUCATIONAL SERVICES [8200] IRS NUMBER: 362855674 STATE OF INCORPORATION: IL FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-56125 FILM NUMBER: 1526878 BUSINESS ADDRESS: STREET 1: FIRST NATIONAL PLAZA STREET 2: 20 SOUTH CLARK STREET 3RD FLOOR CITY: CHICAGO STATE: IL ZIP: 60603 BUSINESS PHONE: 3128999900 MAIL ADDRESS: STREET 1: C/O THE FIRST NATIONAL PLAZA STREET 2: 20 SOUTH CLARK STREET 3RD FLOOR CITY: CHICAGO STATE: IL ZIP: 60603 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: HUGHES HOWARD MEDICAL INSTITUTE CENTRAL INDEX KEY: 0000810386 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] STATE OF INCORPORATION: DE FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 4000 JONES BRIDGE ROAD CITY: CHEVY CHASE STATE: MD ZIP: 20815-6789 BUSINESS PHONE: 3012158500 MAIL ADDRESS: STREET 1: 4000 JONES BRIDGE ROAD CITY: CHEVY CHASE STATE: MD ZIP: 20815-6789 SC 13G/A 1 a2037278zsc13ga.txt SC 13G/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)(1) ARGOSY EDUCATION GROUP, INC. - -------------------------------------------------------------------------------- (Name of Issuer) CLASS A COMMON STOCK - -------------------------------------------------------------------------------- (Title of Class of Securities) 040222101 - -------------------------------------------------------------------------------- (CUSIP Number) 12/31/2000 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ X ] Rule 13d-1 (b) [ ] Rule 13d-1 (c) [ ] Rule 13d-1 (d) - --------------- (1)The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes.) [Continued on the following pages] CUSIP No. 040222101 13G Page 2 of 6 Pages - ---------------------------------------------------------------- 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Howard Hughes Medical Institute 59-0735717 - ---------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF THE MEMBER OF A GROUP (a)[ ] (b)[ ] - ---------------------------------------------------------------- 3. SEC USE ONLY - ---------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - ---------------------------------------------------------------- 5. SOLE VOTING POWER NUMBER OF 0 SHARES --------------------------------- BENEFICIALLY 6. SHARED VOTING POWER OWNED BY EACH 96,700* REPORTING --------------------------------- PERSON 7. SOLE DISPOSITIVE POWER WITH 0 ---------------------------------- 8. SHARED DISPOSITIVE POWER 96,700* - ---------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 96,700* - ---------------------------------------------------------------- 10. CHECK BOX IF AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] - ---------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 6.13% - ---------------------------------------------------------------- 12. TYPE OF REPORTING PERSON EP * See Footnote in Item 4 Below CUSIP No. 040222101 13G Page 3 of 6 Pages Item 1(a). Name of Issuer: ARGOSY EDUCATION GROUP, INC. Item 1(b). Address of Issuer's Principal Executive Offices: First National Plaza 20 South Clark Street 3rd Floor Chicago, IL 60603 Item 2(a). Name of Person Filing: Howard Hughes Medical Institute Item 2(b). Address of Principal Business Office or, if None, Residence: 4000 Jones Bridge Road Chevy Chase, Maryland 20815-6789 Item 2(c). Citizenship: Delaware Item 2(d). Title of Class of Securities: Class A Common Stock Item 2(e). CUSIP Number: 040222101 Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act. (b) [ ] Bank as defined in Section 3(a)(6) of the Act. (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act. CUSIP No. 040222101 13G Page 4 of 6 Pages (d) [ ] Investment Company registered under Section 8 of the Investment Company Act. (e) [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) [ X ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); see item 7; (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J). If this statement is filed pursuant to Rule 13d-1(c), check this box [ ] Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 96,700* (b) Percent of class: 6.13% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote 0 (ii) Shared power to vote or to direct the vote 96,700* (iii) Sole power to dispose or to direct the disposition of 0 (iv) Shared power to dispose or to direct the disposition of 96,700* * The reporting person hereby reports that it has beneficial ownership, shared voting power and shared dispositive power in response to certain Items of Schedule 13G only to the extent that the reporting person may have the right (in accordance with Rule 13d-3(d)(1) under the Act) to acquire such beneficial ownership or voting or dispositive power within 60 days pursuant to termination of the external management agreement pursuant to which the CUSIP No. 040222101 13G Page 5 of 6 Pages securities are held. Pursuant to Rule 13d-4 under the Act, the reporting person hereby disclaims beneficial ownership of the securities as to which this Schedule is filed and expressly declares that the filing of this Schedule 13G shall not be construed as an admission that the reporting person is, for the purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any securities covered by such Schedule. Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Wellington Management Company, LLP has the power to direct the proceeds of the sale of the securities pursuant to a management agreement with the reporting person. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not Applicable. Item 8. Identification and Classification of Members of the Group. Not Applicable. Item 9. Notice of Dissolution of Group. Not Applicable. Item 10. Certification. (a) The following certification shall be included if the statement is filed pursuant to Rule 13d-1(b): By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the CUSIP No. 040222101 13G Page 6 of 6 Pages effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Howard Hughes Medical Institute By: /s/Richard A. Pender --------------------------------------- Name: Richard A. Pender Title: Managing Director - Equities Date: January 17, 2001 -----END PRIVACY-ENHANCED MESSAGE-----